HOME > TOP STORIES
TOP STORIES
-
REGULATORY Japan Research Group to Wrap Up Report on Clinical Trials for Cannabis-Derived Drugs by March-End
February 26, 2021
-
BUSINESS Meiji to Discontinue Sale of Kobayashi Kako Products after Biz Suspension
February 26, 2021
-
BUSINESS MSD’s 9-Valent HPV Vaccine Now Available in Japan
February 25, 2021
-
REGULATORY Japan to Start Elderly Vaccine Rollout from April 12: Minister
February 25, 2021
-
BUSINESS Takeda Launches Japan PI/II Trial of Novavax COVID-19 Vaccine
February 25, 2021
-
REGULATORY MHLW to Revise Dyslipidemia Drug Development Guideline for 1st Time in 30 Years
February 25, 2021
-
BUSINESS Japan Pharma Market Shrinks 2.4% on COVID-19, Price Cuts: IQVIA
February 24, 2021
-
REGULATORY LDP to Set Up Project Team to Strengthen Pharma Sector, Eyes Proposal in May
February 22, 2021
-
ORGANIZATION PhRMA Japan Chief Urges Govt to Return to Pro-Innovation Path, Airs Grievances over Decision-Making on Off-Year Price Cuts
February 19, 2021
-
BUSINESS Mitsubishi Tanabe Accelerating Drug Discovery via Open Innovation, Early-Stage Data Sharing
February 18, 2021
-
REGULATORY Celgene’s CAR-T Liso-Cel Now in Line for Possible March Approval in Japan
February 18, 2021
-
REGULATORY Japan Launches COVID-19 Vaccination Program
February 18, 2021
-
BUSINESS Novo Training Its Sights on Oral Diabetes Market with Rybelsus, Not Switches from GLP-1 Injectables
February 17, 2021
-
REGULATORY COVID-19 Vaccine Being Rolled Out for 40,000 Healthcare Workers in Japan
February 17, 2021
-
BUSINESS Shionogi Pharma Set to Expand CDMO Biz with Continuous Manufacturing, Eyes 10 Billion Yen Sales in FY2024
February 17, 2021
-
REGULATORY 17 Firms Get Approval for Cymbalta Generics, June Listing Eyed
February 16, 2021
-
REGULATORY PMDA Review Report: Pfizer Vaccine’s Efficacy for Variants Not Gauged in Clinical Trials, Continued Info Collection Needed
February 16, 2021
-
BUSINESS Japan’s 1st Humira Biosimilar Hits Market
February 16, 2021
-
REGULATORY Japan Approves Pfizer’s COVID-19 Vaccine, Rollout Set for Mid Week
February 15, 2021
-
BUSINESS Japan Trial Now Underway for Gene Therapy Luxturna; Eyes Riveted on Its Price Tag
February 12, 2021
ページ
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
